Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Direct Laryngoscope Products, Reusable

Active
MN-2312-09Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Health Agency’s Medical Logistics Division, in collaboration with the Defense Logistics Agency Troop Support Medical/Surgical Prime Vendor program, plans to issue a Sources Sought notification around May 8, 2024, to establish a Qualified Suppliers Listing (QSL) for reusable direct laryngoscope products. This effort is not a solicitation for proposals but a market research activity to identify capable vendors for reusable laryngoscope blades and handles used in airway management. The QSL will support a subsequent standardization and incentive agreement process within the MSPV program. Products must exclude single-use or indirect/video laryngoscope components and must comply with the Trade Agreements Act requirements, ensuring they are manufactured in compliant countries unless no equivalent item is available. Interested vendors must either have or be pursuing a Distribution and Pricing Agreement and a commercial agreement with current Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. Vendors must also maintain an active status in the System for Award Management (SAM) and provide a valid Commercial and Government Entity (CAGE) code. Detailed QSL requirements will be available upon release of the QSL Announcement on SAM.gov. This notice serves strictly to inform potential suppliers of the forthcoming opportunity, and responses or inquiries at this stage are not appropriate. The program aims to streamline procurement through a standardized supplier listing supporting medical logistics operations headquartered in Philadelphia, with performance located in Frederick, MD.

General Info

Defense Health Agency seeks vendors for reusable laryngoscope products, establishing Qualified Suppliers Listing May 2024.

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

1

Notice of Intent for Qualified Supplier Listing MN-2312-09 Direct Laryngoscope Products

DOCX, Low prioritysources-sought
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhasePresolicitation
Posted

Presolicitation

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA
Contacts
MMESO Enterprise Wide Standardization
Tara J. Perrien Contracting Officer

Full Description

Show more
The Defense Health Agency (DHA) Medical Logistics (MEDLOG) Division Medical Materiel Enterprise Standardization Office (MMESO) and Defense Logistics Agency (DLA) Troop Support Medical/Surgical Prime Vendor (MSPV) program anticipate issuing a Sources Sought notification for the establishment of a Qualified Suppliers Listing (QSL) for Direct Laryngoscope Products, Reusable through the SAM.gov website on or about 8 May 2024. This is not a request for quote or proposal. Examples of items for this Direct Laryngoscope Products, Reusable product line could include but are not limited to: reusable laryngoscope blades and handles in a variety of sizes and types made from various materials used to visualize and examine the interior of the larynx for placement of an endotracheal tube. This product line excludes single use and indirect/video laryngoscope blades and handles. The primary objective of this effort will be to solicit information and products for evaluation in order to create a QSL. The subject QSL will be the basis of a separate Standardization Action (SA) resulting in an Incentive Agreement (IA). This initiative will be part of the MSPV program which is executed by the DLA Troop Support, Directorate of Medical Materiel. To participate in the QSL process vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the current Medical/Surgical PV for each MMESO Area of Responsibility (AOR), i.e., Cardinal Health, and Owens & Minor. Vendors must validate that their account is Active in the System for Award Management (SAM) and provide Commercial and Government Entity (CAGE) Code. For additional information regarding DLA Troop Support's MSPV program, please access the DLA web site at https://www.medical.dla.mil. All items proposed to be included in this QSL must be on DAPA for the DLA Troop Support MSPV program. The MSPV Program requires that all items be manufactured in a Trade Agreements Act (TAA) Compliant Country (as defined by FAR 52.225-5), unless it is determined that no functionally equivalent item is available from a compliant source. To be eligible for inclusion in the proposed QSL, all vendors are required to complete the DAPA TAA Certification. Detailed information about the QSL requirements will be provided in the QSL Announcement. The purpose of this Notice of Intent to establish a Qualified Supplier List is to inform qualified entities interested in providing these services that the release of the QSL Announcement is imminent. Upon issuance of the QSL Announcement, all relevant information will be available electronically on the SAM.gov website. This Notice of Intent to establish a Qualified Supplier List is for information purposes only. This is not a request for submission of proposals or qualifications. RESPONSES OR OTHER INQUIRIES ARE NOT APPROPRIATE AT THIS TIME.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support. The procurement is for critical Chemical Biological Radiation and Nuclear Personal Protective Equipment, specifically Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure consists of a one-year base period and four one-year option periods, with a target delivery schedule of 100 days and terms set as FOB Origin. Avon Protection Systems Incorporated is the approved source, and while alternate offers are encouraged via specific DLAD procurement notes, they require a complete data package for evaluation. The solicitation has undergone five amendments, with the final closing date extended to September 2, 2026, at 3:00 PM EDT. Key regulatory requirements include compliance with the Buy American Act, the Berry Amendment, and export-control regulations under ITAR and EAR, requiring offerors to have approved US/Canada Joint Certification Program certification. Additionally, the contract incorporates FAR 52.222-90 regarding DEI discrimination and clarifies that while Cybersecurity Maturity Model Certification Level 2 is not required for the initial award, it may be necessary for future continued performance. Price is the sole evaluated factor for award.
All Other Plastics Product Manufacturing

POSTED

about 11 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS